McQuarrie David P.
Chief Commercial Officer
14 filings on record here, covering HPQ, SYM, NTRP, KMTS, NYT, EQBK, LEN, LEN.B, UPBD and others. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-11
CORPORATEFiled 2026-08-05
| Exercise | SYM | Symbotic Inc. | |
| Sell | SYM | Symbotic Inc. | $1,120,490 |
| Exercise | SYM | Symbotic Inc. | |
CORPORATEFiled 2026-08-04
| Other | NTRP | NextTrip, Inc. | $28,975 |
CORPORATEFiled 2026-08-03
| Sell | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $93,758 |
| Sell | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $198,001 |
| Sell | KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $56,551 |
CORPORATEFiled 2026-07-27
| Award | NYT | NEW YORK TIMES CO | |
CORPORATEFiled 2026-07-23
| Gift | EQBK | EQUITY BANCSHARES INC | |
CORPORATEFiled 2026-07-14
| Award | LEN, LEN.B | LENNAR CORP /NEW/ | $1,180 |
CORPORATEFiled 2026-07-09
| Award | UPBD | UPBOUND GROUP, INC. | $26,237 |
CORPORATEFiled 2026-07-02
| Exercise | MEDP | Medpace Holdings, Inc. | |
| Exercise | MEDP | Medpace Holdings, Inc. | |
CORPORATEFiled 2026-06-26
| Exercise | IONS | IONIS PHARMACEUTICALS INC | $474,819 |
| Sell | IONS | IONIS PHARMACEUTICALS INC | $1,142,082 |
| Exercise | IONS | IONIS PHARMACEUTICALS INC | $686,947 |
| Sell | IONS | IONIS PHARMACEUTICALS INC | $1,653,941 |
| Exercise | IONS | IONIS PHARMACEUTICALS INC | $2,839,000 |
| Sell | IONS | IONIS PHARMACEUTICALS INC | $4,029,500 |
| Exercise | IONS | IONIS PHARMACEUTICALS INC | |
| Exercise | IONS | IONIS PHARMACEUTICALS INC | |
| Exercise | IONS | IONIS PHARMACEUTICALS INC | |
CORPORATEFiled 2026-06-23
| Award | ECPG | ENCORE CAPITAL GROUP INC | $179,989 |
CORPORATEFiled 2026-06-22
CORPORATEFiled 2026-06-16
| Sell | GWRE | Guidewire Software, Inc. | $509,645 |
CORPORATEFiled 2026-06-15
| Buy | XRAY | DENTSPLY SIRONA Inc. | $101,200 |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.